Evidence map›Paper›PMID 31776337›Full record

ArticleNature communications2019

Lipid order and charge protect killer T cells from accidental death.

Jesse A Rudd-Schmidt, Adrian W Hodel, Tahereh Noori, Jamie A Lopez, Hyun-Jung Cho, Sandra Verschoor, Annette Ciccone, Joseph A Trapani, Bart W Hoogenboom, Ilia Voskoboinik

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Mechanoregulation of lymphocyte cytotoxicity.Nature reviews. Immunology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Microtubule regulation in cancer cells.Frontiers in cell and developmental biology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Jesse A Rudd-SchmidtKiller Cell Biology Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Adrian W HodelLondon Centre for Nanotechnology, University College London, 19 Gordon Street, London, WC1H 0AH, UK.
Tahereh NooriKiller Cell Biology Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Jamie A LopezKiller Cell Biology Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Hyun-Jung ChoBiological Optical Microscopy Platform, The University of Melbourne, Parkville, VIC, 3010, Australia.
Sandra VerschoorCancer Cell Death Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Annette CicconeCancer Cell Death Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Joseph A TrapaniSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, 3000, Australia.
Bart W HoogenboomLondon Centre for Nanotechnology, University College London, 19 Gordon Street, London, WC1H 0AH, UK. b.hoogenboom@ucl.ac.uk.ORCID http://orcid.org/0000-0002-8882-4324
Ilia VoskoboinikKiller Cell Biology Laboratory, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. ilia.voskoboinik@petermac.org.
The University of Melbourne · AUPeter MacCallum Cancer Centre · AULondon Centre for Nanotechnology · GBBristol-Myers Squibb (Germany) · DE

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J005932/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J006254/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/N015487/1
6 · The paper itself

Abstract

Killer T cells (cytotoxic T lymphocytes, CTLs) maintain immune homoeostasis by eliminating virus-infected and cancerous cells. CTLs achieve this by forming an immunological synapse with their targets and secreting a pore-forming protein (perforin) and pro-apoptotic serine proteases (granzymes) into the synaptic cleft. Although the CTL and the target cell are both exposed to perforin within the synapse, only the target cell membrane is disrupted, while the CTL is invariably spared. How CTLs escape unscathed remains a mystery. Here, we report that CTLs achieve this via two protective properties of their plasma membrane within the synapse: high lipid order repels perforin and, in addition, exposed phosphatidylserine sequesters and inactivates perforin. The resulting resistance of CTLs to perforin explains their ability to kill target cells in rapid succession and to survive these encounters. Furthermore, these mechanisms imply an unsuspected role for plasma membrane organization in protecting cells from immune attack.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell DeathCell LineCell MembraneCholesterolMembrane LipidsMice, TransgenicNatural Killer T-CellsPerforinPhosphatidylserinesT-Lymphocytes, CytotoxicCholesterolMembrane LipidsPerforinPhosphatidylserines

Identifiers

PMID31776337
PMCPMC6881447
OpenAlexW2989734338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.